| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/17/2008 | CN101268372A Potency assays for antibody drug substance binding to FC receptor |
| 09/17/2008 | CN101268101A Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 09/17/2008 | CN101268095A Bifunctional protein anchors |
| 09/17/2008 | CN101267836A Single dose use of CD20-specific binding molecules |
| 09/17/2008 | CN101267835A Reducing interference between oil-containing adjuvants and surfactant-containing antigens |
| 09/17/2008 | CN101267834A 白介素-1偶联物及其用途 Interleukin-1 conjugates and their use |
| 09/17/2008 | CN101267833A Compositions and methods for treating tumors presenting survivin antigens |
| 09/17/2008 | CN101267805A Systems and methods for manufacturing liposomes |
| 09/17/2008 | CN101265457A Vaccine for differentiating porcine actinobacillus pleuropneumonia serum 7-type double-gene deletion mutant of vaccine immunity and virus infection animal and application thereof |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101264327A Magnetic target carrier system |
| 09/17/2008 | CN101264326A Alzheimer's disease treatment method |
| 09/17/2008 | CN101264325A RS7 antibodies |
| 09/17/2008 | CN101264324A Blocking immune response to a foreign antigen using an antagonist which binds to CD20. |
| 09/17/2008 | CN101264323A Respiratory syncytial virus sub-units vaccine, preparation and application |
| 09/17/2008 | CN101264322A Listeria monocytogenes inactivated vaccine and preparation thereof |
| 09/17/2008 | CN100419079C Compositions and methods for therapy and diagnosis of prostate cancer |
| 09/17/2008 | CN100419078C Expression method of glucosal related protein and application thereof |
| 09/17/2008 | CN100419073C Live vaccine for mycoplasma pneumonia of swine and production method thereof |
| 09/17/2008 | CN100419068C Yeast stain for preparing Pres-E1-E2 vaccine of hepatitis B and hepatitis C virus and preparation method thereof |
| 09/17/2008 | CN100418577C Hpv-16 and -18 l1 vlp vaccine. |
| 09/17/2008 | CN100418576C Subcutaneously-administered ganglioside-based vaccine compositions |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425620 FcγRIIB-specific antibodies and methods of use thereof |
| 09/16/2008 | US7425619 FcγRIIB specific antibodies and methods of use thereof |
| 09/16/2008 | US7425618 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| 09/16/2008 | US7425616 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 09/16/2008 | US7425611 Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use |
| 09/16/2008 | US7425609 PRO4330 polypeptides |
| 09/16/2008 | US7425535 Therapeutic pore-forming peptides |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425449 Site specific Listeria integration vectors and methods for using the same |
| 09/16/2008 | US7425447 Host cells expressing 7C10 and 16C10 CD80-specific antibodies |
| 09/16/2008 | US7425446 host cells into which a gene encoding an antibody is introduced, which is resistant to a section which recognizes a sugar chain in which fucose is bound to N-acetylglucosamine in a complex N-glycoside-linked sugar chain; antibodies used for diseases having antibody-dependent cell-mediated cytotoxicity |
| 09/16/2008 | US7425444 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors |
| 09/16/2008 | US7425438 Vector for anti-HPV vaccine and transformed microorganism by the vector |
| 09/16/2008 | US7425437 Human cells comprising sequence encoding early region-1 (E1) gene product of an adenovirus; cultured in suspension to very high densities under serum-free conditions |
| 09/16/2008 | US7425428 Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby |
| 09/16/2008 | US7425338 Clostridial toxin derivatives and methods for treating pain |
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425336 Canine influenza vaccines |
| 09/16/2008 | US7425335 Chimeric T helper-B cell peptide vaccine for Japanese encephalitis virus |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425330 Methods of inhibiting TNFα activity in the blood of a patient |
| 09/16/2008 | US7425329 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 09/16/2008 | US7425328 Comprises immunoglobulin which binds tissue factor and prevents blood coagulation for use as tool in treatment of thrombosis and thromboembolic disorders |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | US7425217 For therapy of tumor, wart, hyperproliferative cellular condition |
| 09/16/2008 | CA2472031C Medical device with coating that promotes endothelial cell adherence and differentiation |
| 09/16/2008 | CA2400319C Coating that promotes endothelial cell adherence |
| 09/16/2008 | CA2313609C Trypanosoma cruzi antigen, gene encoding therefor, and methods of detecting and treating chagas disease |
| 09/16/2008 | CA2292730C Stabilized antibody formulation |
| 09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/16/2008 | CA2132091C Antibodies to alphavbeta3 integrin |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/16/2008 | CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/12/2008 | WO2008109757A2 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | WO2008109742A1 Modulation of complement system activation for treatment of bleeding-related inflammation |
| 09/12/2008 | WO2008109669A2 Bacterial extract for respiratory disorders and proces for its preparation |
| 09/12/2008 | WO2008109667A2 Bacterial extract for digestive or urinary tract disorders and process for its preparation |
| 09/12/2008 | WO2008109560A2 Amelioration of cellular stress response |
| 09/12/2008 | WO2008109533A2 Human antibodies that bind multiple irta family proteins, and uses thereof |
| 09/12/2008 | WO2008109517A1 Neurodegenerative disease treatment using jak/stat inhibition |
| 09/12/2008 | WO2008109440A2 Predicting response to a her dimerisation inhibitor based on low her3 expression |
| 09/12/2008 | WO2008109237A2 Macrophage cell-lines for propagation of porcine reproductive and respiratory syndrome virus |
| 09/12/2008 | WO2008109155A2 Compositions and methods for treatment of cervical cancer |
| 09/12/2008 | WO2008109034A2 Modulating pdx-1 with pcif1, methods and uses thereof |
| 09/12/2008 | WO2008108986A2 Methods and compositions for treating tumor diseases |
| 09/12/2008 | WO2008108980A2 Devices and methods for extracorporeal ablation of circulating cells |
| 09/12/2008 | WO2008108918A1 Human antibodies against hepatitis c virus (hcv) uses thereof |
| 09/12/2008 | WO2008108910A2 Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy |
| 09/12/2008 | WO2008108830A2 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 09/12/2008 | WO2008108679A1 Tumor vaccine, a method for producing a tumor vaccine and a method for carrying out antitumor immunotherapy |
| 09/12/2008 | WO2008108386A1 Pharmaceutical composition |
| 09/12/2008 | WO2008108257A1 Cancer antigen-specific t-cell receptor gene, peptide encoded by the gene, and use of them |
| 09/12/2008 | WO2008107641A1 Liposome preparation |
| 09/12/2008 | WO2008107400A1 Hcv polyepitope construct and uses thereof |
| 09/12/2008 | WO2008107370A1 Novel method and compositions |
| 09/12/2008 | WO2008107187A1 Antibodies specific for rubella virus |
| 09/12/2008 | WO2008106980A2 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/12/2008 | WO2008106803A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | WO2008106763A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | WO2008106731A1 A target for breast cancer therapy and/or diagnosis |
| 09/12/2008 | WO2008089569A9 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 09/12/2008 | WO2008086006A9 Sp35 antibodies and uses thereof |
| 09/12/2008 | WO2008080623A3 Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo |
| 09/12/2008 | WO2008079172A9 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof |
| 09/12/2008 | WO2008074851A3 Method for inhibiting the expression of endogenous erythropoietin (epo) |
| 09/12/2008 | WO2008054540A3 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| 09/12/2008 | WO2008054354A3 Assays for s1oo inhibitors |
| 09/12/2008 | WO2008051363A3 Stable polypeptide formulations |
| 09/12/2008 | WO2008049990A3 Use of an anti-cd151 antibody in the treatment of cancer |
| 09/12/2008 | WO2008049073A3 Compositions for the treatment of inflammation in the brain and other tissues |
| 09/12/2008 | WO2007140244A3 Vaccination of young animals against lawsonia intracellularis infections |
| 09/12/2008 | WO2007130327A3 Influenza virus-like particle (vlp) compositions |
| 09/12/2008 | WO2007103572A3 Extracorporeal removal of microvesicular particles |